Overexpression of miR-4521 in breast cancer cell led to ROS induced DNA damage and increased cell death suggesting its potential as novel FOXM1 inhibitor which can be further exploited in breast cancer mouse model alone or in combination with platinum drugs or PARP inhibitor (Figure 7). This evidence concerns the gene FOXM1 and breast cancer.